Evidence map›Paper›PMID 22152480›Full record

ArticleMolecular cell2011

FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.

Hiroto Katoh, Zhaohui S Qin, Runhua Liu, Lizhong Wang, Weiquan Li, Xiangzhi Li, Lipeng Wu, Zhanwen Du, Robert Lyons, Chang-Gong Liu and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Hiroto KatohDivision of Immunotherapy, Department of Surgery, University of Michigan School of Medicine and Cancer Center, Ann Arbor, MI 48109, USA.
Zhaohui S Qin
Runhua Liu
Lizhong Wang
Weiquan Li
Xiangzhi Li
Lipeng Wu
Zhanwen Du
Robert Lyons
Chang-Gong Liu
Xiuping Liu
Yali Dou
Pan Zheng
Yang Liu
University of Michigan–Ann Arbor · USThe University of Texas MD Anderson Cancer Center · USEmory University · USInstitute of Biophysics · CN

Funding

Tumor burden and T cell immunityR01CA058033 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YANG · 1992 to 2013
$3.3M
FoxP3 as the X-Linked Breast Cancer Suppressor GeneR01CA120901 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YANG · 2007 to 2010
$1.6M
NCI NIH HHS R01 CA058033NCI NIH HHS R01 CA120901
6 · The paper itself

Abstract

Both H4K16 acetylation and H3K4 trimethylation are required for gene activation. However, it is still largely unclear how these modifications are orchestrated by transcriptional factors. Here, we analyzed the mechanism of the transcriptional activation by FOXP3, an X-linked suppressor of autoimmune diseases and cancers. FOXP3 binds near transcriptional start sites of its target genes. By recruiting MOF and displacing histone H3K4 demethylase PLU-1, FOXP3 increases both H4K16 acetylation and H3K4 trimethylation at the FOXP3-associated chromatins of multiple FOXP3-activated genes. RNAi-mediated silencing of MOF reduced both gene activation and tumor suppression by FOXP3, while both somatic mutations in clinical cancer samples and targeted mutation of FOXP3 in mouse prostate epithelial cells disrupted nuclear localization of MOF. Our data demonstrate a pull-push model in which a single transcription factor orchestrates two epigenetic alterations necessary for gene activation and provide a mechanism for somatic inactivation of the FOXP3 protein function in cancer cells.

Indexed as

AcetylationBreast NeoplasmsCell Line, TumorCell NucleusFemaleForkhead Transcription FactorsGene Expression RegulationHEK293 CellsHistone AcetyltransferasesHistonesHumansJumonji Domain-Containing Histone DemethylasesMethylationMutationNuclear ProteinsRepressor ProteinsForkhead Transcription FactorsFOXP3 protein, humanHistone AcetyltransferasesHistonesJumonji Domain-Containing Histone DemethylasesKAT8 protein, humanKDM5B protein, humanNuclear ProteinsRepressor Proteins

Identifiers

PMID22152480
PMCPMC3243051
OpenAlexW2044559322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.